Search Results - "CHWALISZ, K"

Treatment and Relapse Prevention of Typical and Atypical Optic Neuritis by Saitakis, George, Chwalisz, Bart K

“…Optic neuritis (ON) is an inflammatory condition involving the optic nerve. Several important typical and atypical ON variants are now recognized. Typical ON…”
Get full text

Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist by Taylor, Hugh S, Giudice, Linda C, Lessey, Bruce A, Abrao, Mauricio S, Kotarski, Jan, Archer, David F, Diamond, Michael P, Surrey, Eric, Johnson, Neil P, Watts, Nelson B, Gallagher, J. Chris, Simon, James A, Carr, Bruce, Dmowski, W. Paul, Leyland, Nicholas, Rowan, Jean P, Duan, W. Rachel, Ng, Juki, Schwefel, Brittany, Thomas, James W, Jain, Rita I, Chwalisz, Kristof

“…In two randomized trials, two different doses of the oral gonadotropin-releasing hormone antagonist elagolix significantly reduced endometriosis-related…”
Get full text

Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials by Stewart, E A, Diamond, M P, Williams, A R W, Carr, B R, Myers, E R, Feldman, R A, Elger, W, Mattia-Goldberg, C, Schwefel, B M, Chwalisz, K

“…Abstract STUDY QUESTION Can asoprisnil, a selective progesterone receptor modulator, provide clinically meaningful improvements in heavy menstrual bleeding…”
Get full text

Treatment of IgG4-related disease-associated hypertrophic pachymeningitis with intrathecal rituximab: a case report by Balaban, Denis T, Hutto, Spencer K, Panzarini, Bruno P, O'Shea, Aileen, Varma, Aditi, Jones, Pamela S, Chwalisz, Bart K, Stone, John H, Venna, Nagagopal

“…IgG4-related disease-associated hypertrophic pachymeningitis (IgG4RD-HP) is a fibroinflammatory autoimmune disorder in which diagnosis is difficult without…”
Get full text

COVID-19-induced headache in Boston and the vicinity by Chwalisz, Bart K., Le, Vi K., Cheng, Jennifer R., Jain, Aayushee, Brandon Westover, M., Cheng, Hsinlin T.

“…Headache is a common neurological symptom of Coronavirus disease 2019 (COVID-19) patients. However, the prevalence, comorbidities, and ethnic susceptibilities…”
Get full text

The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata by Williams, A.R.W., Critchley, H.O.D., Osei, J., Ingamells, S., Cameron, I.T., Han, C., Chwalisz, K.

“…BACKGROUND Asoprisnil is a selective progesterone receptor modulator with mixed progesterone agonist/antagonist activity which controls uterine bleeding via an…”
Get full text

Use of elagolix for the management of endometriosis-associated pain: secondary efficacy results from two randomized, placebo-controlled studies by Surrey, E, Giudice, L.C, Lessey, B.A, Taylor, H.S, Williams, L.A, Rowan, J.P, Chwalisz, K, Schwefel, B, Thomas, J.W, Jain, R.I

Get full text

The effect of elagolix on the endometrium: safety results from two randomized, placebo-controlled studies in women with endometriosis-associated pain by Diamond, M.P, Simon, J, Lessey, B.A, Taylor, H.S, Rowan, J.P, Chwalisz, K, Schwefel, B, Thomas, J.W, Jain, R.I, Williams, L.A

Get full text

Cerebral amyloid angiopathy and related inflammatory disorders by Chwalisz, B.K.

“…Inflammatory cerebral amyloid angiopathy is a largely reversible inflammatory vasculopathy that develops in an acute or subacute fashion in reaction to amyloid…”
Get full text

Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors by Guidon, Amanda C, Burton, Leeann B, Chwalisz, Bart K, Hillis, James, Schaller, Teilo H, Amato, Anthony A, Betof Warner, Allison, Brastianos, Priscilla K, Cho, Tracey A, Clardy, Stacey L, Cohen, Justine V, Dietrich, Jorg, Dougan, Michael, Doughty, Christopher T, Dubey, Divyanshu, Gelfand, Jeffrey M, Guptill, Jeffrey T, Johnson, Douglas B, Juel, Vern C, Kadish, Robert, Kolb, Noah, LeBoeuf, Nicole R, Linnoila, Jenny, Mammen, Andrew L, Martinez-Lage, Maria, Mooradian, Meghan J, Naidoo, Jarushka, Neilan, Tomas G, Reardon, David A, Rubin, Krista M, Santomasso, Bianca D, Sullivan, Ryan J, Wang, Nancy, Woodman, Karin, Zubiri, Leyre, Louv, William C, Reynolds, Kerry L

“…Expanding the US Food and Drug Administration–approved indications for immune checkpoint inhibitors in patients with cancer has resulted in therapeutic success…”
Get full text

Elagolix for the management of heavy menstrual bleeding (HMB) associated with uterine fibroids (UF): results from a phase 2a proof-of-concept study by Archer, D.F, Chwalisz, K, Feldman, R, Stewart, E.A, Lukes, A.S, North, J, Gao, J, Williams, L.A, Jain, R

Get full text

Elagolix, an oral gonadotropin-releasing hormone antagonist, for the management of endometriosis-associated pain: safety and efficacy results from two double-blind, randomized, placebo-controlled studies by Taylor, H.S, Giudice, L.C, Lessey, B.A, Abrao, M, Kotarski, J, Williams, L.A, Rowan, J.P, Chwalisz, K, Duan, W.R, Schwefel, B, Thomas, J.W, Jain, R.I

Get full text

The impact of elagolix on quality of life in women with endometriosis-associated pain: results from two randomized, placebo-controlled studies using the endometriosis health profile questionnaire by Taylor, H.S, Surrey, E, Soliman, A.M, Castelli-Haley, J, Rowan, J.P, Chwalisz, K, Thomas, J.W, Schwefel, B, Williams, L.A, Jain, R.I

Get full text

The effect of elagolix on bone mineral density: safety results from two randomized, placebo-controlled studies in women with endometriosis-associated pain by Archer, D.F, Watts, N, Gallagher, C, Simon, J, Duan, W.R, Rowan, J.P, Chwalisz, K, Schwefel, B, Thomas, J.W, Jain, R.I, Williams, L.A

Get full text

Diagnostic accuracy of urinary cytokeratin 19 fragment for endometriosis by Lessey, B A, Savaris, R F, Ali, S, Brophy, S, Tomazic-Allen, S, Chwalisz, K

“…Endometriosis affects up to 10% of women of reproductive age and 176 million women worldwide. The prevalence in women with infertility is between 30% and 50%…”
Get more information

Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer by Spitz, A, Young, J M, Larsen, L, Mattia-Goldberg, C, Donnelly, J, Chwalisz, K

“…Background: This open-label study evaluated the efficacy and safety of a new leuprolide acetate 45 mg 6-month depot formulation in 151 men with prostate cancer…”
Get full text

Update on Neuro-ophthalmic Manifestations of Immune Checkpoint Inhibitors by Chen, Amalie, Chwalisz, Bart K.

“…Purpose of Review Immune checkpoint inhibitor (ICI) use has been on the rise for treatment of many different malignancies. Subsequently, more has been learned…”
Get full text

Neuro-ophthalmic manifestations of coronavirus disease 19 by Tisdale, Alanna K., Chwalisz, Bart K.

“…PURPOSE OF REVIEWTo provide a summary of the neuro-ophthalmic manifestations of coronavirus disease 19 (COVID-19), documented in the literature thus far…”
Get full text

The neurology of IGG4-related disease by Saitakis, G., Chwalisz, B.K.

“…IgG4-related disease (IgG4-RD) is emerging as a fibro-inflammatory entity affecting multiple organs, including manifold neurologic manifestations. This review…”
Get full text

Neuro-ophthalmic manifestations of Susac syndrome by Redler, Yael, Chwalisz, Bart K

“…This review discusses general features and organ-specific presentations of Susac syndrome as well as diagnosis and treatment. Latest literature regarding…”
Get full text